Pooja Jadiya to Animals, Genetically Modified
This is a "connection" page, showing publications Pooja Jadiya has written about Animals, Genetically Modified.
Connection Strength
0.926
-
Jadiya P, Nazir A. Environmental toxicants as extrinsic epigenetic factors for parkinsonism: studies employing transgenic C. elegans model. CNS Neurol Disord Drug Targets. 2012 Dec; 11(8):976-83.
Score: 0.442
-
Jadiya P, Mir SS, Nazir A. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model. Cell Signal. 2018 05; 45:71-80.
Score: 0.158
-
Jadiya P, Fatima S, Baghel T, Mir SS, Nazir A. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans. Mol Neurobiol. 2016 11; 53(9):6288-6300.
Score: 0.135
-
Jadiya P, Khan A, Sammi SR, Kaur S, Mir SS, Nazir A. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease. Biochem Biophys Res Commun. 2011 Oct 07; 413(4):605-10.
Score: 0.101
-
Fatima S, Haque R, Jadiya P. Ida-1, the Caenorhabditis elegans orthologue of mammalian diabetes autoantigen IA-2, potentially acts as a common modulator between Parkinson's disease and Diabetes: role of Daf-2/Daf-16 insulin like signalling pathway. PLoS One. 2014; 9(12):e113986.
Score: 0.032
-
Sashidhara KV, Modukuri RK, Jadiya P, Dodda RP, Kumar M, Sridhar B, Kumar V, Haque R, Siddiqi MI, Nazir A. Benzofuran-chalcone hybrids as potential multifunctional agents against Alzheimer's disease: synthesis and in vivo studies with transgenic Caenorhabditis elegans. ChemMedChem. 2014 Dec; 9(12):2671-84.
Score: 0.031
-
Kaur S, Sammi SR, Jadiya P, Nazir A. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans. CNS Neurol Disord Drug Targets. 2012 Jun 01; 11(4):387-94.
Score: 0.027